Search Results
Bispecific antibodies enable synthetic agonistic receptor T-cell therapy in melanoma
Immuno-Oncology Virtual Summit 2020
The Promise of NK Engager Bispecific Antibodies (with CSO Dr. Wei Li)
Neha Mehta-Shah, MD, MSCI, on Bispecific Antibodies in B-cell Lymphomas
ITOC 2022 highlights: B-cell engineering for cancer treatment
Advances in Antibody Discovery for Bispecific Therapeutics | Biology Solutions | Antibody Screening
The use of chemokines in cancer immunotherapy
Treating Lymphoma with Bispecific Antibodies | LRF Webinars
Context Therapeutics announces bispecific antibody clinical candidate to treat CLDN6+ cancers
DSG3-CAART: A novel CAAR T-cell therapy in pemphigus vulgaris
How can Elicera’s iTANK technology boost CAR-T cell therapies?
Anna Wu: "Beyond Biopsies - Enabling Precision Medicine through Antibody-Based Imaging"
